Wilex looks for funding as development grinds to a halt
This article was originally published in Scrip
Executive Summary
Wilex has engaged the investment banking firm Burrill Securities to help it find partners willing to finance its portfolio. Existing investors, which include dievini Hopp Biotech, are not showing significant interest in bailing out the waning German biotech firm.